Pharmaceutical companies face a growing challenge: keeping track of the ever-expanding body of published literature related to their products.

Whether for regulatory filings, pharmacovigilance reporting, or monitoring off-label usage, literature reviews are essential — but they’re also time-consuming and resource-intensive.

But what if you could automatically scan, summarize, and assess every relevant study as it’s published without expanding your headcount?

Leveraging AI-Driven Literature Review Tools

Court Square Group can help automate the collection, analysis, and reporting of data from:

1. Scientific publications (e.g., PubMed)
2. Clinical trial databases
3. Internal repositories and legacy systems
4. Grey literature
5. Manual files
6. Public patent databases and more

With these AI-Integrated Tools, Your Team Can

• Continuously monitor public and proprietary literature
• Summarize documents using advanced NLP models
• Tag and rank based on relevance
• Deduplicate and organize references
• Export findings in your preferred format (PDF, Word, XML, etc.)
• Collaborate via shared workspaces, comments, and version control
• Maintain accuracy with a built-in validation package
• Stay compliant with GxP, HIPAA, GDPR (product-dependent)

Smarter Use of Subject Matter Experts

Subject matter expertise is essential but shouldn’t be wasted on tasks that AI can handle. Court Square Group gives you the tools you need to free up your internal teams so they can focus on high-value analysis, while AI handles the heavy lifting such as:

• Running broad or narrow reviews by product, therapeutic area, or target subject
• Maintaining a living baseline of all known references for each product
• Tracking changes and additions in real time as new literature becomes available

With automation, you can regularly evaluate every product every year, not just a select few.

• Accelerate Insights
• Reduce Manual Workload
• Maintain Compliance

See how you can supercharge your literature review process with Court Square Group.